FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 313:1123-1125 October 31, 1985 Number 18 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The synthesis of the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25-(OH)2D), is thought to be relatively insensitive to the serum concentration of its precursor, 25-hydroxyvitamin D (25-OH-D). We compared the effect of oral administration of 25-OH-D3 (50 micrograms per day for one month) on serum concentrations of calcium, phosphate, parathyroid hormone, 25-OH-D, and 1,25-(OH)2D in five healthy adults and in six patients with primary hyperparathyroidism. In normal adults the mean (+/- S.D.) serum level of 25-OH-D rose from 18 +/- 9 to 136 +/- 47 ng per milliliter; no significant changes were observed in the other serum levels. In contrast, comparable increases in the levels of circulating 25-OH-D in patients with primary hyperparathyroidism caused a consistent slight rise in serum calcium and phosphate levels, a partial suppression of parathyroid hormone, and a sharp increase in the level of 1,25-(OH)2D. During this period a significant positive correlation was found between serum concentrations of 25-OH-D and 1,25-(OH)2D (P less than 0.001). These results provide evidence that in patients with primary hyperparathyroidism, levels of circulating 1,25-(OH)2D may be more dependent on the prevailing serum concentrations of 25-OH-D than they are in normal adults.

This article has been cited by other articles:

• Rejnmark, L., Vestergaard, P., Heickendorff, L., Mosekilde, L. (2008). Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D.. Eur J Endocrinol 158: 571-576 [Abstract] [Full Text]  
• Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P, Mosekilde, L (2006). Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.. Eur J Endocrinol 155: 237-244 [Abstract] [Full Text]  
• Goussous, R., Song, L., Dallal, G. E., Dawson-Hughes, B. (2005). Lack of Effect of Calcium Intake on the 25-Hydroxyvitamin D Response to Oral Vitamin D3. J. Clin. Endocrinol. Metab. 90: 707-711 [Abstract] [Full Text]